Cathay Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	9,252	5,347	5,390	6,295	9,629
Trading Asset Securities	0.47	0.47	0.47	0.47	0.47
Cash & Short-Term Investments	9,252	5,347	5,391	6,295	9,629
Cash Growth	73.02%	-0.81%	-14.37%	-34.62%	36.78%
Accounts Receivable	519.81	459.88	385.52	463.56	275.22
Other Receivables	7.77	10.56	10.35	11.79	6.58
Receivables	527.58	470.43	395.88	475.35	281.8
Inventory	1,440	1,181	1,466	1,574	1,185
Prepaid Expenses	-	7.29	10.57	-	-
Other Current Assets	511.66	381.4	307.18	131.44	298.68
Total Current Assets	11,731	7,387	7,571	8,475	11,395
Property, Plant & Equipment	10,255	9,849	9,376	6,670	2,969
Long-Term Investments	203.67	133.78	142.73	49.51	53.21
Other Intangible Assets	728.5	685.04	703.85	777.87	768.46
Long-Term Deferred Tax Assets	278.12	210.37	158.88	88.28	52.2
Long-Term Deferred Charges	3.21	6.42	4.98	7.17	9.58
Other Long-Term Assets	682.61	750.4	876.48	1,759	938.51
Total Assets	23,882	19,021	18,833	17,827	16,185
Accounts Payable	1,404	135.44	167.85	240.08	248.83
Accrued Expenses	24.46	30.32	21.54	32.47	42.34
Short-Term Debt	301.22	1,247	746.25	161.47	743.51
Current Portion of Long-Term Debt	12.81	37.17	784.37	5.38	-
Current Income Taxes Payable	38.99	32.94	55.54	30.7	45.4
Current Unearned Revenue	30.61	35.81	10.48	17.81	14.64
Other Current Liabilities	194.68	1,399	1,624	936.28	123.01
Total Current Liabilities	2,006	2,918	3,410	1,424	1,218
Long-Term Debt	188.96	613.26	245.33	960.5	-
Long-Term Unearned Revenue	371.98	389.29	405.18	404.39	293.03
Total Liabilities	2,567	3,920	4,060	2,789	1,511
Common Stock	721.29	583.38	583.38	583.28	416.68
Additional Paid-In Capital	14,246	8,520	8,526	8,540	8,688
Retained Earnings	2,819	2,546	2,167	1,905	1,539
Treasury Stock	-109.06	-155.13	-126.19	-94.67	-
Comprehensive Income & Other	23.17	12.77	14.45	14.69	8.23
Total Common Equity	17,700	11,507	11,164	10,949	10,652
Minority Interest	3,615	3,594	3,609	4,089	4,022
Shareholders' Equity	21,315	15,101	14,773	15,038	14,674
Total Liabilities & Equity	23,882	19,021	18,833	17,827	16,185
Total Debt	503	1,897	1,776	1,127	743.51
Net Cash (Debt)	8,749	3,450	3,615	5,168	8,886
Net Cash Growth	153.60%	-4.56%	-30.05%	-41.84%	26.22%
Net Cash Per Share	12.79	5.93	6.21	8.87	15.24
Filing Date Shares Outstanding	717.28	718.95	581.32	582.15	583.35
Total Common Shares Outstanding	717.28	582.75	581.68	582.15	583.35
Working Capital	9,725	4,469	4,161	7,051	10,177
Book Value Per Share	24.68	19.75	19.19	18.81	18.26
Tangible Book Value	16,971	10,822	10,460	10,171	9,883
Tangible Book Value Per Share	23.66	18.57	17.98	17.47	16.94
Buildings	-	1,958	1,815	1,357	988.18
Machinery	-	3,330	3,216	2,979	1,807
Construction In Progress	-	5,949	5,443	3,164	758.31

Source: S&P Global Market Intelligence. Standard template. Financial Sources.